IBRX — ImmunityBio, Inc. stock price, charts and financials

QT62ImmunityBio, Inc.

ImmunityBio, Inc. (NASDAQ: IBRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.95
-0.20-2.80%
OverviewShort InterestFilings
IBRXQT62ImmunityBio, Inc.·NASDAQ
6.95-2.80%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 202610-QQuarterly report
Aug 04, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 01, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 05, 20264Statement of changes in beneficial ownership
May 18, 20268-KCurrent report
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 2026ARSAnnual report to shareholders
Apr 09, 20268-KCurrent report
Apr 06, 20268-KCurrent report
Apr 02, 20264Statement of changes in beneficial ownership
Mar 31, 20268-KCurrent report
#1 / 25 of 248
Page
▼
/ 10